Rtw Investments, LP has bought stock on 31 days since Apr 2019
10% owner at Kailera Therapeutics, Inc., and 11 other companies
SEC CIK 0001493215 · Filings on SEC.gov ↗
Rtw Investments, LP's record
3 months after each buy, from the first price a copier could get.
4 buys since 2019 with 3 months of prices.
Companies
- KLRA Kailera Therapeutics, Inc.10% owner
- OBIO Orchestra BioMed Holdings, Inc.10% owner
- DMTK Dermtech, Inc.10% owner
- LABP Landos Biopharma, Inc.10% owner
- MIST Milestone Pharmaceuticals Inc.10% owner
- RCOR Renovacor, Inc.10% owner
- RNA Atrium Therapeutics, Inc.10% owner
- RCKT Rocket Pharmaceuticals, Inc.Director and 10% owner
- TARS Tarsus Pharmaceuticals, Inc.10% owner
- RXDX Prometheus Biosciences, Inc.10% owner
- TELA TELA Bio, Inc.10% owner
- STOK Stoke Therapeutics, Inc.10% owner
Every filing
38 filings since Apr 2019, newest first
Kailera Therapeutics, Inc.
10% owner
Orchestra Biomed Holdings, Inc.
10% owner
Orchestra Biomed Holdings, Inc.
10% owner
Dermtech, Inc.
10% owner
Landos Biopharma, Inc.
10% owner
Milestone Pharmaceuticals Inc.
10% owner
Renovacor, Inc.
10% owner
Renovacor, Inc.
10% owner
Renovacor, Inc.
10% owner
Renovacor, Inc.
10% owner
Renovacor, Inc.
10% owner
Renovacor, Inc.
10% owner
Renovacor, Inc.
10% owner
Renovacor, Inc.
10% owner
Avidity Biosciences, Inc.
10% owner
Rocket Pharmaceuticals, Inc.
Director and 10% owner
Tarsus Pharmaceuticals, Inc.
10% owner
Prometheus Biosciences, Inc.
10% owner
Landos Biopharma, Inc.
10% owner
Dermtech, Inc.
10% owner
Rocket Pharmaceuticals, Inc.
Director and 10% owner
Milestone Pharmaceuticals Inc.
10% owner
Milestone Pharmaceuticals Inc.
10% owner
Dermtech, Inc.
10% owner
Dermtech, Inc.
10% owner
Milestone Pharmaceuticals Inc.
10% owner
Milestone Pharmaceuticals Inc.
10% owner
Tela Bio, Inc.
10% owner
Rocket Pharmaceuticals, Inc.
Director and 10% owner
Stoke Therapeutics, Inc.
10% owner
Stoke Therapeutics, Inc.
10% owner
Stoke Therapeutics, Inc.
10% owner
Milestone Pharmaceuticals Inc.
10% owner
Milestone Pharmaceuticals Inc.
10% owner
Stoke Therapeutics, Inc.
10% owner
Stoke Therapeutics, Inc.
10% owner
Milestone Pharmaceuticals Inc.
10% owner
Rocket Pharmaceuticals, Inc.
Director and 10% owner
About Rtw Investments, LP
RTW Investments, LP is a life sciences investment and innovation firm headquartered in New York with additional offices in London and Shanghai( The firm operates as a full lifecycle investor, providing capital and expertise to support scientists and entrepreneurs across the biotech and medtech sectors, from early-stage academic programs through mature publicly traded companies( As of its latest SEC filings, RTW Investments manages a portfolio of 91 holdings with a disclosed portfolio value of approximately $9.98 billion USD( with top investments including Madrigal Pharmaceuticals, Insmed Incorporated, and PTC Therapeutics(
The firm's investment strategy is built on a foundation of deep research focused on bringing innovative new products to patients( RTW Investments maintains a diversified portfolio across the life sciences sector, with particular emphasis on health services and biotech companies( The firm operates with 10 clients and discretionary assets under management of approximately $14.1 billion( positioning it as a significant player in life sciences venture capital and crossover investing.
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.